LUPUS ERYTHEMATOSUS
Clinical trials for LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental Donor-Cell therapy takes aim at tough autoimmune diseases
Disease control OngoingThis early-stage study tests a therapy called SC291, made from donor immune cells, in 7 people with severe lupus or vasculitis that hasn't improved with standard treatments. The goal is to see if it is safe and tolerable, and to get a first look at whether it can control the dise…
Matched conditions: LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Gene-Edited cell therapy for lupus trial pulled before it started
Disease control TerminatedThis early-stage study aimed to test a single infusion of CB-010, a CRISPR-edited CAR-T cell therapy made from donor cells, in people with severe lupus that did not respond to standard treatments. The trial was withdrawn before enrolling any participants, so no results are availa…
Matched conditions: LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:51 UTC